Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy
Simple Summary
- Supplementary File 1:
ZIP-Document (ZIP, 603 KiB)
Jóri, B.; Schatz, S.; Kaller, L.; Kah, B.; Roeper, J.; Ramdani, H.O.; Diehl, L.; Hoffknecht, P.; Grohé, C.; Griesinger, F.; Tiemann, M.; Heukamp, L.C.; Falk, M. Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy. Cancers 2021, 13, 2861. https://doi.org/10.3390/cancers13122861
Jóri B, Schatz S, Kaller L, Kah B, Roeper J, Ramdani HO, Diehl L, Hoffknecht P, Grohé C, Griesinger F, Tiemann M, Heukamp LC, Falk M. Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy. Cancers. 2021; 13(12):2861. https://doi.org/10.3390/cancers13122861
Chicago/Turabian StyleJóri, Balázs, Stefanie Schatz, Len Kaller, Bettina Kah, Julia Roeper, Hayat O. Ramdani, Linda Diehl, Petra Hoffknecht, Christian Grohé, Frank Griesinger, Markus Tiemann, Lukas C. Heukamp, and Markus Falk. 2021. "Comparison of Resistance Spectra after First and Second Line Osimertinib Treatment Detected by Liquid Biopsy" Cancers 13, no. 12: 2861. https://doi.org/10.3390/cancers13122861